I-123 METAIODOBENZYLGUANIDINE IMAGING OF THE HEART IN IDIOPATHIC CONGESTIVE CARDIOMYOPATHY AND CARDIAC TRANSPLANTS

被引:0
|
作者
GLOWNIAK, JV
TURNER, FE
GRAY, LL
PALAC, RT
LAGUNASSOLAR, MC
WOODWARD, WR
机构
[1] VET ADM MED CTR,MED SERV,CARDIOL SECT,PORTLAND,OR 97207
[2] OREGON HLTH SCI UNIV,DEPT DIAGNOST RADIOL & NEUROL,PORTLAND,OR 97201
[3] UNIV CALIF DAVIS,CROCKER NUCL LAB,DAVIS,CA 95616
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:1182 / 1191
页数:10
相关论文
共 50 条
  • [1] CARDIAC I-123 METAIODOBENZYLGUANIDINE IMAGING AS A PROGNOSTIC GUIDE IN CONGESTIVE-HEART-FAILURE
    MERLET, P
    BENVENUTI, C
    DUBOISRANDE, JL
    POUILLART, F
    VALETTE, H
    DUBOC, D
    LOISANCE, D
    SYROTA, A
    CASTAIGNE, A
    CIRCULATION, 1993, 88 (04) : 257 - 257
  • [2] IMAGING OF THE SYMPATHETIC NERVOUS-SYSTEM OF THE HEART WITH I-123 METAIODOBENZYLGUANIDINE IN CARDIOMYOPATHY
    GROTZ, J
    FRANITZA, R
    MODDER, G
    HOSSMANN, V
    ZEITSCHRIFT FUR KARDIOLOGIE, 1988, 77 (05): : 278 - 281
  • [3] MYOCARDIAL IMAGING WITH I-123 METAIODOBENZYLGUANIDINE
    WALTON, S
    COSTA, DC
    ELL, PJ
    EMANUEL, RW
    BRITISH HEART JOURNAL, 1985, 54 (06): : 617 - 617
  • [4] Comparison of the prognostic value of cardiac I-123 metaiodobenzylguanidine and neurohumoral factors in patients with congestive heart failure
    Matsui, T
    Tsutamoto, T
    Kusukawa, J
    Tsutsui, T
    Mabuchi, N
    Maeda, K
    Mitsunami, K
    Kinoshita, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 480A - 480A
  • [5] Cardiac I-123 metaiodobenzylguanidine uptake in predicting early and late mortality in patients with congestive heart failure
    Lekakis, JP
    Nanas, JN
    Prassopoulos, VK
    Raptis, GT
    Alexopoulos, GE
    Terovitis, JV
    Kostamis, PK
    Stamatelopoulos, SF
    Moulopoulos, SD
    CIRCULATION, 1997, 96 (08) : 2106 - 2106
  • [6] Myocardial clearance of I-123 metaiodobenzylguanidine in dilated cardiomyopathy
    Yamanari H.
    Sakamoto T.
    Takenaka S.
    Saito H.
    Koyama S.
    Ohe T.
    Annals of Nuclear Medicine, 1997, 11 (4) : 325 - 329
  • [7] CHARACTERISTICS OF I-123 METAIODOBENZYLGUANIDINE MYOCARDIAL IMAGES IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY AND TACHYARRHYTHMIA
    MAENO, M
    ISHIDA, Y
    HIROSE, Y
    HAYASHIDA, K
    TAKAHASHI, N
    HAMADA, S
    MIYATAKE, K
    OHE, T
    NISHIMURA, T
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P81 - P81
  • [8] COMPARISON OF MYOCARDIAL DISTRIBUTIONS BETWEEN I-123 BETAMETHYLIODOPHENYLPENTADECANOIC ACID (BMIPP) AND I-123 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) IN HYPERTROPHIC CARDIOMYOPATHY (HCM)
    HAMAMOTO, K
    TANADA, S
    HIGASHINO, H
    MURASE, K
    TSUDA, T
    SUGAWARA, Y
    INOUE, T
    KIMURA, Y
    HAMADA, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 664 - 664
  • [9] QUANTITATIVE-ANALYSIS OF I-123 METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) UPTAKE IN HYPERTROPHIC CARDIOMYOPATHY
    NAKAJIMA, K
    BUNKO, H
    TAKI, J
    SHIMIZU, M
    MURAMORI, A
    HISADA, K
    AMERICAN HEART JOURNAL, 1990, 119 (06) : 1329 - 1337
  • [10] Prognostic impact of quantitative cardiac 123I-metaiodobenzylguanidine imaging in patients with congestive heart failure
    Nishimura, S
    Ohta, Y
    Katoh, K
    Tamaki, T
    Yumoto, K
    Yamauchi, Y
    Yoshino, A
    CIRCULATION, 1997, 96 (08) : 2474 - 2474